171 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Letendre SL, Chen H, McKhann A, Roa J, Vecchio A, Daar ES, Berzins B, Hunt PW, Marra CM, Campbell TB, Coombs RW, Ma Q, Swaminathan S, Macatangay BJC, Morse GD, ... ... Robertson K, et al. Antiretroviral Therapy Intensification for Neurocognitive Impairment in HIV. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 37183889 DOI: 10.1093/cid/ciad265  0.526
2022 Sen S, An H, Oakes J, Eron J, Robertson K, Powers W. Effects of early human immunodeficiency virus infection on cerebral white matter blood flow autoregulation. Aids (London, England). PMID 36111546 DOI: 10.1097/QAD.0000000000003378  0.315
2022 Opsteen S, Moylan D, Taiwo BO, Robertson KR, Overton ET, Cutter GR, Sabbaj S, Heath SL, Shacka JJ. Brief Report: Intracellular Cystatin B Levels Are Altered in HIV-Infected Participants With Respect to Neurocognitive Status and Antiretroviral Therapy. Journal of Acquired Immune Deficiency Syndromes (1999). 91: 485-489. PMID 36083516 DOI: 10.1097/QAI.0000000000003086  0.502
2021 Kaewpoowat Q, Rerkasem A, Rerkasem K, Robertson KR, Aita SL, Roth RM, Yasri S, Choovuthayakorn J, Ausayakhun S, Supparatpinyo K, Robbins NM. Cardio-ankle vascular index of increased arterial wall stiffness is associated with neurocognitive impairment in well-controlled HIV. Hiv Medicine. PMID 34859556 DOI: 10.1111/hiv.13213  0.381
2021 Sen S, An H, Sollman M, Oakes J, Eron J, Robertson K, Powers W. Reduction in Cerebral Oxygen Metabolism in Subcortical Regions may be a Biomarker of Cognitive Decline in People Living with HIV. European Journal of Neurology. PMID 34821434 DOI: 10.1111/ene.15196  0.367
2021 Longino AA, Paul R, Wang Y, Lama JR, Brandes P, Ruiz E, Correa C, Keating S, Spudich SS, Pilcher C, Vecchio A, Pasalar S, Bender Ignacio RA, Valdez R, Dasgupta S, ... Robertson K, et al. HIV disease dynamics, markers of inflammation and CNS injury during primary HIV infection and their relationship to cognitive performance. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 34629415 DOI: 10.1097/QAI.0000000000002832  0.505
2021 Aita SL, Kaewpoowat Q, Yasri S, Rerkasem A, Rerkasem K, Choovuthayakorn J, Ausayakhun S, Robertson K, Roth RM, Robbins NM. Psychometric utility of the international HIV dementia scale and Montreal Cognitive Assessment in HIV-associated asymptomatic neurocognitive impairment. Journal of Neurovirology. PMID 34185242 DOI: 10.1007/s13365-021-00991-z  0.35
2021 Vecchio A, Nakigozi G, Nakasujja N, Kisakye A, Batte J, Mayanja R, Anok A, Robertson K, Wawer MJ, Sacktor N, Rubin LH, Saylor D. Assessment, prevalence, and correlates of frailty among middle-aged adults with HIV in rural Uganda. Journal of Neurovirology. PMID 33788138 DOI: 10.1007/s13365-021-00969-x  0.363
2020 Gay CL, Neo DT, Devanathan AS, Kuruc JD, McGee KS, Schmitz JL, Sebastian J, Shaheen NJ, Ferrari G, McKellar M, Fiscus SA, Hicks CB, Robertson K, Kashuba ADM, Eron JJ, et al. Efficacy, pharmacokinetics and neurocognitive performance of dual, NRTI-sparing antiretroviral therapy in acute HIV-infection. Aids (London, England). PMID 32773474 DOI: 10.1097/Qad.0000000000002652  0.554
2020 Vecchio A, Robertson K, Saylor D, Nakigozi G, Nakasujja N, Kisakye A, Batte J, Mayanja R, Anok A, Reynolds SJ, Quinn TC, Gray R, Wawer MJ, Sacktor N, Rubin LH. Neurocognitive Effects of Antiretroviral Initiation Among People Living With HIV in Rural Uganda. Journal of Acquired Immune Deficiency Syndromes (1999). 84: 534-542. PMID 32692113 DOI: 10.1097/Qai.0000000000002385  0.515
2020 Groff BR, Wiesman AI, Rezich MT, O'Neill J, Robertson KR, Fox HS, Swindells S, Wilson TW. Age-related visual dynamics in HIV-infected adults with cognitive impairment. Neurology(R) Neuroimmunology & Neuroinflammation. 7. PMID 32102916 DOI: 10.1212/Nxi.0000000000000690  0.561
2020 Molinaro M, Sacktor N, Nakigozi G, Anok A, Batte J, Kisakye A, Myanja R, Nakasujja N, Robertson KR, Gray RH, Wawer MJ, Saylor D. Utility of the International HIV Dementia Scale for HIV-Associated Neurocognitive Disorder. Journal of Acquired Immune Deficiency Syndromes (1999). 83: 278-283. PMID 32032278 DOI: 10.1097/Qai.0000000000002257  0.594
2020 Halpin SN, Ge L, Mehta CC, Gustafson D, Robertson KR, Rubin LH, Sharma A, Vance D, Valcour V, Waldrop-Valverde D, Ofotokun I. Psychosocial Resources and Emotions in Women Living With HIV Who Have Cognitive Impairment: Applying the Socio-Emotional Adaptation Theory. Research and Theory For Nursing Practice. 34: 49-64. PMID 31937636 DOI: 10.1891/1541-6577.34.1.49  0.361
2020 Adewumi OM, Dukhovlinova E, Shehu NY, Zhou S, Council O, Akanbi MO, Taiwo B, Ogunniyi A, Robertson K, Kanyama C, Hosseinipour M, Swanstrom R. HIV-1 CNS COMPARTMENTALIZATION AND CYTOKINE INTERPLAY IN NON-SUBTYPE B HIV-1 INFECTIONS IN NIGERIA AND MALAWI. Aids Research and Human Retroviruses. PMID 31914800 DOI: 10.1089/Aid.2019.0245  0.524
2020 Chow FC, Lyass A, Mahoney TF, Massaro JM, Triant VA, Wu K, Berzins B, Robertson K, Ellis RJ, Tassiopoulos K, Taiwo B, D'Agostino RB. Baseline 10-year cardiovascular risk scores predict cognitive function in older persons, and particularly women, living with HIV infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31899478 DOI: 10.1093/Cid/Ciz1214  0.408
2019 Farhadian SF, Mistry H, Kirchwey T, Chiarella J, Calvi R, Chintanaphol M, Patel P, Landry ML, Robertson K, Spudich SS. Markers of CNS Injury in Adults Living With HIV With CSF HIV Not Detected vs Detected <20 Copies/mL. Open Forum Infectious Diseases. 6: ofz528. PMID 31893212 DOI: 10.1093/Ofid/Ofz528  0.506
2019 Awori V, Nakigozi G, Kisakye A, Batte J, Anok A, Mayanja R, Nakasujja N, Robertson KR, Gray RH, Wawer MJ, Sacktor N, Saylor D. The Veterans Aging Cohort Study Index is not associated with HIV-associated neurocognitive disorders in Uganda. Journal of Neurovirology. PMID 31721082 DOI: 10.1007/S13365-019-00806-2  0.563
2019 OʼMeara T, Kong Y, Chiarella J, Price RW, Chaudhury R, Liu X, Spudich S, Robertson K, Emu B, Lu L. Exosomal MicroRNAs Associate With Neuropsychological Performance in Individuals With HIV Infection on Antiretroviral Therapy. Journal of Acquired Immune Deficiency Syndromes (1999). 82: 514-522. PMID 31714431 DOI: 10.1097/Qai.0000000000002187  0.535
2019 Vecchio AC, Marra CM, Schouten J, Jiang H, Kumwenda J, Supparatpinyo K, Hakim J, Sacktor N, Campbell TB, Tripathy S, Kumarasamy N, La Rosa A, Santos B, Silva MT, Kanyama C, ... ... Robertson K, et al. Distal Sensory Peripheral Neuropathy in Human Immunodeficiency Virus Type 1-Positive Individuals Before and After Antiretroviral Therapy Initiation in Diverse Resource-Limited Settings. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31630166 DOI: 10.1093/Cid/Ciz745  0.555
2019 Robertson K, Landay A, Miyahara S, Vecchio A, Masters MC, Brown TT, Taiwo BO. Limited correlation between systemic biomarkers and neurocognitive performance before and during HIV treatment. Journal of Neurovirology. PMID 31468473 DOI: 10.1007/S13365-019-00795-2  0.431
2019 Spudich S, Robertson KR, Bosch RJ, Gandhi RT, Cyktor JC, Mar H, Macatangay BJ, Lalama CM, Rinaldo C, Collier AC, Godfrey C, Eron JJ, McMahon D, Jacobs JL, Koontz D, et al. Persistent HIV-infected cells in cerebrospinal fluid are associated with poorer neurocognitive performance. The Journal of Clinical Investigation. 130. PMID 31305262 DOI: 10.1172/Jci127413  0.565
2019 Vecchio A, Sacktor N, Saylor D, Robertson K. Neurocognitive Complications of HIV Infection in Low-Income Countries. Current Topics in Behavioral Neurosciences. PMID 31297744 DOI: 10.1007/7854_2019_92  0.605
2019 Rubin LH, Saylor D, Nakigozi G, Nakasujja N, Robertson K, Kisakye A, Batte J, Mayanja R, Anok A, Lofgren SM, Boulware DR, Dastgheyb R, Reynolds SJ, Quinn TC, Gray RH, et al. Heterogeneity in neurocognitive change trajectories among people with HIV starting antiretroviral therapy in Rakai, Uganda. Journal of Neurovirology. PMID 31218522 DOI: 10.1007/S13365-019-00768-5  0.404
2019 Vecchio AC, Robertson KR. Markers of persistent HIV replication in the CNS. The Lancet. Hiv. PMID 31208950 DOI: 10.1016/S2352-3018(19)30182-1  0.587
2019 Saylor D, Kumar A, Nakigozi G, Anok A, Batte J, Kisakye A, Mayanja R, Nakasujja N, Robertson KR, Gray RH, Wawer MJ, Pardo CA, Sacktor N. Interleukin-6 is associated with mortality and neuropsychiatric outcomes in antiretroviral-naïve adults in Rakai, Uganda. Journal of Neurovirology. PMID 31165368 DOI: 10.1007/S13365-019-00759-6  0.473
2019 Kalayjian RC, Robertson KR, Albert JM, Fichthenbaum CJ, Brown TT, Taiwo BO. Plasma Cystatin C Associates with HIV-Associated Neurocognitive Disorder but is a Poor Diagnostic Marker in Antiretroviral Therapy Treated Individuals. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 30939531 DOI: 10.1097/Qai.0000000000002016  0.445
2019 Sacktor N, Saylor D, Nakigozi G, Nakasujja N, Robertson K, Grabowski MK, Kisakye A, Batte J, Mayanja R, Anok A, Gray RH, Wawer MJ. Effect of HIV Subtype and Antiretroviral therapy on HIV-associated neurocognitive disorder (HAND) stage in Rakai, Uganda. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 30865184 DOI: 10.1097/Qai.0000000000001992  0.546
2019 Srinivas N, Joseph SB, Robertson K, Kincer LP, Menezes P, Adamson L, Schauer AP, Blake KH, White N, Sykes C, Luciw P, Eron JJ, Forrest A, Price R, Spudich S, et al. Predicting efavirenz concentrations in the brain tissue of HIV-infected individuals and exploring their relationship to neurocognitive impairment. Clinical and Translational Science. PMID 30675981 DOI: 10.1111/Cts.12620  0.365
2019 Saylor D, Nakigozi G, Pardo CA, Kisakye A, Kumar A, Nakasujja N, Robertson KR, Gray RH, Wawer MJ, Sacktor N. Vitamin D is not associated with HIV-associated neurocognitive disorder in Rakai, Uganda. Journal of Neurovirology. PMID 30671778 DOI: 10.1007/S13365-018-00719-6  0.419
2019 Sohail S, Nakigozi G, Anok A, Batte J, Kisakye A, Mayanja R, Nakasujja N, Robertson KR, Gray RH, Wawer MJ, Sacktor N, Saylor D. Headache prevalence and its functional impact among HIV-infected adults in rural Rakai District, Uganda. Journal of Neurovirology. PMID 30607892 DOI: 10.1007/S13365-018-0710-9  0.534
2019 Cutler R, Trentman S, Jandarov R, Brown J, Robertson K, Fichtenbaum C. 366. Severe Neurologic Impairment Persists Despite Potent ART in HIV Encephalopathy Open Forum Infectious Diseases. 6. DOI: 10.1093/Ofid/Ofz360.439  0.597
2019 Kaewpoowat Q, Thongton W, Robertson K, Chaiwarith R, Robbins N, Supparatpinyo K. 365. Neurocognitive Function Change after Switching from Efavirenz to Rilpivirine in HIV-Infected Adults: A Randomized Control Trial Open Forum Infectious Diseases. 6. DOI: 10.1093/Ofid/Ofz360.438  0.574
2018 Joseph SB, Kincer LP, Bowman NM, Evans C, Vinikoor MJ, Lippincott CK, Gisslén M, Spudich S, Menezes P, Robertson K, Archin N, Kashuba A, Eron JJ, Price RW, Swanstrom R. HIV-1 RNA Detected in the CNS after Years of Suppressive Antiretroviral Therapy Can Originate from a Replicating CNS Reservoir or Clonally Expanded Cells. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30561541 DOI: 10.1093/Cid/Ciy1066  0.502
2018 Kisakye A, Saylor D, Sacktor N, Nakigozi G, Nakasujja N, Robertson K, Anok A, Wawer M, Gray R. Caregiver versus self-reported activities of daily living among HIV-positive persons in Rakai, Uganda. Aids Care. 1-4. PMID 30554522 DOI: 10.1080/09540121.2018.1557591  0.585
2018 Silverman A, O'Meara T, Le L, Robertson K, Spudich S. Residency Training: Progressive gait difficulty and incontinence in a 40-year-old man with HIV. Neurology. 91: 1065-1070. PMID 30510020 DOI: 10.1212/Wnl.0000000000006619  0.484
2018 Lebov JF, Brown LM, MacDonald PDM, Robertson K, Bowman NM, Hooper SR, Becker-Dreps S. Review: Evidence of Neurological Sequelae in Children With Acquired Zika Virus Infection. Pediatric Neurology. 85: 16-20. PMID 30343688 DOI: 10.1016/J.Pediatrneurol.2018.03.001  0.314
2018 Lew BJ, McDermott TJ, Wiesman AI, O'Neill J, Mills MS, Robertson KR, Fox HS, Swindells S, Wilson TW. Neural dynamics of selective attention deficits in HIV-associated neurocognitive disorder. Neurology. PMID 30333162 DOI: 10.1212/Wnl.0000000000006504  0.499
2018 Robertson K, Maruff P, Ross LL, Wohl D, Small CB, Edelstein H, Shaefer MS. Similar neurocognitive outcomes after 48 weeks in HIV-1-infected participants randomized to continue tenofovir/emtricitabine + atazanavir/ritonavir or simplify to abacavir/lamivudine + atazanavir. Journal of Neurovirology. PMID 30298202 DOI: 10.1007/S13365-018-0680-Y  0.495
2018 Farhadian SF, Mehta SS, Zografou C, Robertson K, Price RW, Pappalardo J, Chiarella J, Hafler DA, Spudich SS. Single-cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid during virologically suppressed HIV. Jci Insight. 3. PMID 30232286 DOI: 10.1172/Jci.Insight.121718  0.511
2018 Robertson KR, Jiang H, Kumwenda J, Supparatpinyo K, Marra CM, Berzins B, Hakim J, Sacktor N, Campbell TB, Schouten J, Mollan K, Tripathy S, Kumarasamy N, La Rosa A, Santos B, et al. HIV Associated Neurocognitive Impairment in Diverse Resource Limited Settings. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30219843 DOI: 10.1093/Cid/Ciy767  0.594
2018 Chow FC, Makanjuola A, Wu K, Berzins B, Kim KA, Ogunniyi A, Ellis R, Robertson K, Tassiopolous K, Taiwo B. Physical activity is associated with lower odds of cognitive impairment in women but not men living with HIV infection. The Journal of Infectious Diseases. PMID 30137500 DOI: 10.1093/Infdis/Jiy503  0.499
2018 Robertson K, Oladeji B, Jiang H, Kumwenda J, Supparatpinyo K, Campbell T, Hakim J, Tripathy S, Hosseinipour M, Marra CM, Kumarasamy N, Evans S, Vecchio A, La Rosa A, et al. HIV-1 and TB Co-infection in Multinational Resource Limited Settings: Increased neurological dysfunction. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30137250 DOI: 10.1093/Cid/Ciy718  0.522
2018 Spooner RK, Wiesman AI, Mills MS, O'Neill J, Robertson KR, Fox HS, Swindells S, Wilson TW. Aberrant oscillatory dynamics during somatosensory processing in HIV-infected adults. Neuroimage. Clinical. 20: 85-91. PMID 30094159 DOI: 10.1016/J.Nicl.2018.07.009  0.54
2018 Akpa O, Miyahara S, Taiwo B, Evans S, Berzins B, Robertson K. Similar changes in neuropsychological functioning in english and spanish speaking HIV patients. Brain and Behavior. e01083. PMID 30047258 DOI: 10.1002/Brb3.1083  0.519
2018 Erlandson KM, Perez J, Abdo M, Robertson K, Ellis RJ, Koletar SL, Kalayjian R, Taiwo B, Palella FJ, Tassiopoulos K. Frailty, Neurocognitive Impairment, or Both in Predicting Poor Health Outcomes Among Adults Living with HIV. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 29788039 DOI: 10.1093/Cid/Ciy430  0.51
2018 Landis RC, Abayomi EA, Bain B, Greene E, Janossy G, Joseph P, Kerrigan D, McCoy JP, Nunez CA, O'Gorman M, Pastoors A, Parekh B, Quimby K, Quinn TC, Robertson K, et al. Shifting the HIV Paradigm from Care to Cure: Proceedings from the Caribbean Expert Summit in Barbados, August 2017. Aids Research and Human Retroviruses. PMID 29732897 DOI: 10.1089/Aid.2017.0310  0.547
2018 Wiesman AI, O'Neill J, Mills MS, Robertson KR, Fox HS, Swindells S, Wilson TW. Aberrant occipital dynamics differentiate HIV-infected patients with and without cognitive impairment. Brain : a Journal of Neurology. PMID 29672678 DOI: 10.1093/Brain/Awy097  0.58
2018 Wright EJ, Grund B, Robertson KR, Cysique L, Brew BJ, Collins GL, Poehlman-Roediger M, Vjecha M, Penalva de Oliveira A, Standridge B, Carey C, Avihingsanon A, Florence E, Lundgren JD, Arenas-Pinto A, et al. No Neurocognitive Advantage for Immediate Antiretroviral Treatment in adults with greater than 500 CD4+ T Cell Counts. Aids (London, England). PMID 29424786 DOI: 10.1097/Qad.0000000000001778  0.409
2018 Halpin SN, Ge L, Mehta CC, Gustafson D, Robertson K, Vance D, Ofotokun I. Psychosocial Resources And Emotions In Women With Hiv-Related Cognitive Impairment Innovation in Aging. 2: 579-579. DOI: 10.1093/Geroni/Igy023.2145  0.465
2017 Erlandson KM, Kitch D, Wester WC, Kalayjian RC, Overton ET, Castillo-Mancilla J, Koletar SL, Benson CA, Campbell TB, Robertson K, Lok JJ. The Impact of Statin and ACE-inhibitor/Angiotensin Receptor Blocker Therapy on Cognitive Function in Adults with HIV Infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 29020174 DOI: 10.1093/Cid/Cix645  0.483
2017 Adetunji AA, Kuti MA, Audu RA, Muyibi SA, Imhansoloeva M, Mosuro OA, Solanke EA, Akpa OM, Irabor AE, Ladipo M, Berzins B, Robertson K, Ogunniyi A, Adewole IF, Taiwo BO. Discordant rapid HIV tests: lessons from a low-resource community. Hiv Medicine. PMID 28758335 DOI: 10.1111/Hiv.12541  0.586
2017 van den Dries LWJ, Wagener MN, Jiskoot LC, Visser M, Robertson KR, Adriani KS, van Gorp ECM. Neurocognitive Impairment in a Chronically Well-Suppressed HIV-Infected Population: The Dutch TREVI Cohort Study. Aids Patient Care and Stds. 31: 329-334. PMID 28753395 DOI: 10.1089/Apc.2017.0038  0.534
2017 Saylor D, Nakigozi G, Nakasujja N, Robertson K, Gray RH, Wawer MJ, Sacktor N. Peripheral neuropathy in HIV-infected and uninfected patients in Rakai, Uganda. Neurology. PMID 28679596 DOI: 10.1212/Wnl.0000000000004136  0.511
2017 Coban H, Robertson K, Smurzynski M, Krishnan S, Wu K, Bosch RJ, Collier AC, Ellis RJ. Impact of aging on neurocognitive performance in previously antiretroviral-naïve HIV+ individuals on their first suppressive regimen. Aids (London, England). PMID 28471765 DOI: 10.1097/Qad.0000000000001523  0.557
2017 Rahimy E, Li FY, Hagberg L, Fuchs D, Robertson K, Meyerhoff DJ, Zetterberg H, Price RW, Gisslén M, Spudich S. Blood-Brain Barrier Disruption Is Initiated During Primary HIV Infection and Not Rapidly Altered by Antiretroviral Therapy. The Journal of Infectious Diseases. PMID 28368497 DOI: 10.1093/Infdis/Jix013  0.549
2017 Cordero DM, Towe SL, Chen NK, Robertson KR, Madden DJ, Huettel SA, Meade CS. Cocaine dependence does not contribute substantially to white matter abnormalities in HIV infection. Journal of Neurovirology. PMID 28251596 DOI: 10.1007/S13365-017-0512-5  0.577
2017 Wilson TW, Proskovec AL, Heinrichs-Graham E, O'Neill J, Robertson KR, Fox HS, Swindells S. Aberrant Neuronal Dynamics during Working Memory Operations in the Aging HIV-Infected Brain. Scientific Reports. 7: 41568. PMID 28155864 DOI: 10.1038/Srep41568  0.416
2016 Abassi M, Morawski BM, Nakigozi G, Nakasujja N, Kong X, Meya DB, Robertson K, Gray R, Wawer MJ, Sacktor N, Boulware DR. Cerebrospinal fluid biomarkers and HIV-associated neurocognitive disorders in HIV-infected individuals in Rakai, Uganda. Journal of Neurovirology. PMID 27995575 DOI: 10.1007/S13365-016-0505-9  0.522
2016 Sandkovsky U, Podany AT, Fletcher CV, Owen A, Felton-Coleman A, Winchester LC, Robertson K, Swindells S. Impact of efavirenz pharmacokinetics and pharmacogenomics on neuropsychological performance in older HIV-infected patients. The Journal of Antimicrobial Chemotherapy. PMID 27655857 DOI: 10.1093/Jac/Dkw403  0.563
2016 Yechoor N, Towe SL, Robertson KR, Westreich D, Nakasujja N, Meade CS. Utility of a brief computerized battery to assess HIV-associated neurocognitive impairment in a resource-limited setting. Journal of Neurovirology. PMID 27245592 DOI: 10.1007/S13365-016-0456-1  0.586
2016 Sen S, An H, Menezes P, Oakes J, Eron J, Lin W, Robertson K, Powers W. Increased Cortical Cerebral Blood Flow in Asymptomatic Human Immunodeficiency Virus-Infected Subjects. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. PMID 27160382 DOI: 10.1016/J.Jstrokecerebrovasdis.2016.03.045  0.445
2016 Wright PW, Pyakurel A, Vaida FF, Price RW, Lee E, Peterson J, Fuchs D, Zetterberg H, Robertson KR, Walter R, Meyerhoff DJ, Spudich SS, Ances BM. Putamen volume and its clinical and neurological correlates in primary HIV infection. Aids (London, England). PMID 27045376 DOI: 10.1097/Qad.0000000000001103  0.584
2016 Robertson K, Jiang H, Evans SR, Marra CM, Berzins B, Hakim J, Sacktor N, Silva MT, Campbell TB, Nair A, Schouten J, Kumwenda J, Supparatpinyo K, Tripathy S, et al. International neurocognitive normative study: neurocognitive comparison data in diverse resource-limited settings: AIDS Clinical Trials Group A5271. Journal of Neurovirology. PMID 26733457 DOI: 10.1007/S13365-015-0415-2  0.368
2016 Chen LH, Peterson J, Robertson K, Fuchs D, Price R, Spudich S. Past Substance Use Affects Central Nervous System (CNS) Inflammation in Human Immunodeficiency Virus Infection Open Forum Infectious Diseases. 3. DOI: 10.1093/Ofid/Ofw194.60  0.313
2015 Oladeji BD, Taiwo B, Mosuro O, Fayemiwo SA, Abiona T, Fought AJ, Robertson K, Ogunniyi A, Adewole IF. Suicidal Behavior and Associations with Quality of Life among HIV/AIDS-Infected Patients in Ibadan, Nigeria. Journal of the International Association of Providers of Aids Care. PMID 26586788 DOI: 10.1177/2325957415617829  0.546
2015 Taiwo BO, Chan ES, Fichtenbaum CJ, Ribaudo H, Tsibris A, Klingman KL, Eron JJ, Berzins B, Robertson K, Landay A, Ofotokun I, Brown T. Less Bone Loss With Maraviroc- Versus Tenofovir-Containing Antiretroviral Therapy in the AIDS Clinical Trials Group A5303 Study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 26060295 DOI: 10.1093/Cid/Civ455  0.313
2015 Brew BJ, Robertson K, Wright EJ, Churchill M, Crowe SM, Cysique LA, Deeks S, Garcia JV, Gelman B, Gray LR, Johnson T, Joseph J, Margolis DM, Mankowski JL, Spencer B. HIV eradication symposium: will the brain be left behind? Journal of Neurovirology. 21: 322-34. PMID 25750070 DOI: 10.1007/S13365-015-0322-6  0.574
2015 Wright EJ, Grund B, Cysique LA, Robertson KR, Brew BJ, Collins G, Shlay JC, Winston A, Read TR, Price RW. Factors associated with neurocognitive test performance at baseline: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. Hiv Medicine. 16: 97-108. PMID 25711328 DOI: 10.1111/Hiv.12238  0.553
2015 Meade CS, Towe SL, Skalski LM, Robertson KR. Independent effects of HIV infection and cocaine dependence on neurocognitive impairment in a community sample living in the southern United States. Drug and Alcohol Dependence. 149: 128-35. PMID 25697913 DOI: 10.1016/J.Drugalcdep.2015.01.034  0.487
2015 Wright PW, Vaida FF, Fernández RJ, Rutlin J, Price RW, Lee E, Peterson J, Fuchs D, Shimony JS, Robertson KR, Walter R, Meyerhoff DJ, Spudich S, Ances BM. Cerebral white matter integrity during primary HIV infection. Aids (London, England). 29: 433-42. PMID 25513818 DOI: 10.1097/Qad.0000000000000560  0.51
2015 Underwood J, Robertson KR, Winston A. Could antiretroviral neurotoxicity play a role in the pathogenesis of cognitive impairment in treated HIV disease?. Aids (London, England). 29: 253-61. PMID 25426811 DOI: 10.1097/Qad.0000000000000538  0.539
2015 Wilson TW, Heinrichs-Graham E, Becker KM, Aloi J, Robertson KR, Sandkovsky U, White ML, O'Neill J, Knott NL, Fox HS, Swindells S. Multimodal neuroimaging evidence of alterations in cortical structure and function in HIV-infected older adults. Human Brain Mapping. 36: 897-910. PMID 25376125 DOI: 10.1002/Hbm.22674  0.59
2015 Towe S, Robertson K, King LJ, Meade CS. Effects of HIV infection and cocaine dependence on neurocognitive impairment Drug and Alcohol Dependence. 146: e6-e7. DOI: 10.1016/J.Drugalcdep.2014.09.699  0.5
2014 Sacktor N, Robertson K. Evolving clinical phenotypes in HIV-associated neurocognitive disorders. Current Opinion in Hiv and Aids. 9: 517-20. PMID 25203640 DOI: 10.1097/Coh.0000000000000102  0.557
2014 Robertson K, Bayon C, Molina JM, McNamara P, Resch C, Muñoz-Moreno JA, Kulasegaram R, Schewe K, Burgos-Ramirez A, De Alvaro C, Cabrero E, Guion M, Norton M, van Wyk J. Screening for neurocognitive impairment, depression, and anxiety in HIV-infected patients in Western Europe and Canada. Aids Care. 26: 1555-61. PMID 25029599 DOI: 10.1080/09540121.2014.936813  0.424
2014 Mollan KR, Smurzynski M, Eron JJ, Daar ES, Campbell TB, Sax PE, Gulick RM, Na L, O'Keefe L, Robertson KR, Tierney C. Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data. Annals of Internal Medicine. 161: 1-10. PMID 24979445 DOI: 10.7326/M14-0293  0.404
2014 Kelly CM, van Oosterhout JJ, Ngwalo C, Stewart RC, Benjamin L, Robertson KR, Khoo S, Allain TJ, Solomon T. HIV associated neurocognitive disorders (HAND) in Malawian adults and effect on adherence to combination anti-retroviral therapy: a cross sectional study. Plos One. 9: e98962. PMID 24915530 DOI: 10.1371/Journal.Pone.0098962  0.5
2014 Wang SX, Ho EL, Grill M, Lee E, Peterson J, Robertson K, Fuchs D, Sinclair E, Price RW, Spudich S. Peripheral neuropathy in primary HIV infection associates with systemic and central nervous system immune activation. Journal of Acquired Immune Deficiency Syndromes (1999). 66: 303-10. PMID 24732871 DOI: 10.1097/Qai.0000000000000167  0.574
2014 Robertson K, Yosief S. Neurocognitive assessment in the diagnosis of HIV-associated neurocognitive disorders. Seminars in Neurology. 34: 21-6. PMID 24715485 DOI: 10.1055/S-0034-1372339  0.543
2014 Archin NM, Bateson R, Tripathy MK, Crooks AM, Yang KH, Dahl NP, Kearney MF, Anderson EM, Coffin JM, Strain MC, Richman DD, Robertson KR, Kashuba AD, Bosch RJ, Hazuda DJ, et al. HIV-1 expression within resting CD4+ T cells after multiple doses of vorinostat. The Journal of Infectious Diseases. 210: 728-35. PMID 24620025 DOI: 10.1093/Infdis/Jiu155  0.448
2014 Sacktor N, Nakasujja N, Redd AD, Manucci J, Laeyendecker O, Wendel SK, Porcella SF, Martens C, Bruno D, Skolasky RL, Okonkwo OC, Robertson K, Musisi S, Katabira E, Quinn TC. HIV subtype is not associated with dementia among individuals with moderate and advanced immunosuppression in Kampala, Uganda. Metabolic Brain Disease. 29: 261-8. PMID 24515303 DOI: 10.1007/S11011-014-9498-3  0.616
2014 Gold JA, Grill M, Peterson J, Pilcher C, Lee E, Hecht FM, Fuchs D, Yiannoutsos CT, Price RW, Robertson K, Spudich S. Longitudinal characterization of depression and mood states beginning in primary HIV infection. Aids and Behavior. 18: 1124-32. PMID 24385231 DOI: 10.1007/S10461-013-0688-5  0.53
2013 Becker KM, Heinrichs-Graham E, Fox HS, Robertson KR, Sandkovsky U, O'Neill J, Swindells S, Wilson TW. Decreased MEG beta oscillations in HIV-infected older adults during the resting state. Journal of Neurovirology. 19: 586-94. PMID 24297500 DOI: 10.1007/S13365-013-0220-8  0.549
2013 Grund B, Wright EJ, Brew BJ, Price RW, Roediger MP, Bain MP, Hoy JF, Shlay JC, Vjecha MJ, Robertson KR. Improved neurocognitive test performance in both arms of the SMART study: impact of practice effect. Journal of Neurovirology. 19: 383-92. PMID 23943468 DOI: 10.1007/S13365-013-0190-X  0.508
2013 Sandkovsky U, Robertson KR, Meza JL, High RR, Bonasera SJ, Fisher CM, Marsh AJ, Sheehy MK, Fox HS, Swindells S. Pilot study of younger and older HIV-infected adults using traditional and novel functional assessments. Hiv Clinical Trials. 14: 165-74. PMID 23924589 DOI: 10.1310/Hct1404-165  0.451
2013 Wilson TW, Fox HS, Robertson KR, Sandkovsky U, O'Neill J, Heinrichs-Graham E, Knott NL, Swindells S. Abnormal MEG oscillatory activity during visual processing in the prefrontal cortices and frontal eye-fields of the aging HIV brain. Plos One. 8: e66241. PMID 23840428 DOI: 10.1371/Journal.Pone.0066241  0.541
2013 Wilson TW, Heinrichs-Graham E, Robertson KR, Sandkovsky U, O'Neill J, Knott NL, Fox HS, Swindells S. Functional brain abnormalities during finger-tapping in HIV-infected older adults: a magnetoencephalography study. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 8: 965-74. PMID 23749418 DOI: 10.1007/S11481-013-9477-1  0.526
2013 Gongvatana A, Harezlak J, Buchthal S, Daar E, Schifitto G, Campbell T, Taylor M, Singer E, Algers J, Zhong J, Brown M, McMahon D, So YT, Mi D, Heaton R, ... Robertson K, et al. Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy. Journal of Neurovirology. 19: 209-18. PMID 23613008 DOI: 10.1007/S13365-013-0162-1  0.552
2013 Peluso MJ, Meyerhoff DJ, Price RW, Peterson J, Lee E, Young AC, Walter R, Fuchs D, Brew BJ, Cinque P, Robertson K, Hagberg L, Zetterberg H, Gisslén M, Spudich S. Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection. The Journal of Infectious Diseases. 207: 1703-12. PMID 23460748 DOI: 10.1093/Infdis/Jit088  0.507
2013 Joseph J, Achim CL, Boivin MJ, Brew BJ, Clifford DB, Colosi DA, Ellis RJ, Heaton RK, Gallo-Diop A, Grant I, Kanmogne GD, Kumar M, Letendre S, Marcotte TD, Nath A, ... ... Robertson K, et al. Global NeuroAIDS roundtable. Journal of Neurovirology. 19: 1-9. PMID 23354550 DOI: 10.1007/S13365-012-0143-9  0.587
2013 Sacktor N, Nakasujja N, Okonkwo O, Skolasky RL, Robertson K, Musisi S, Katabira E. Longitudinal neuropsychological test performance among HIV seropositive individuals in Uganda. Journal of Neurovirology. 19: 48-56. PMID 23315423 DOI: 10.1007/S13365-012-0139-5  0.543
2013 Nakasujja N, Miyahara S, Evans S, Lee A, Musisi S, Katabira E, Robertson K, Ronald A, Clifford DB, Sacktor N. Randomized trial of minocycline in the treatment of HIV-associated cognitive impairment. Neurology. 80: 196-202. PMID 23269596 DOI: 10.1212/Wnl.0B013E31827B9121  0.517
2013 Upton CT, Taiwo B, Robertson KR. Neurotoxicity of antiretroviral therapy Future Virology. 8: 469-475. DOI: 10.2217/Fvl.13.30  0.503
2013 Meyer A, Robertson K, Bukusi E, Birbeck G, Cohen C, Oyaro P, Price R. Are practice effects an important confounder of longitudinal studies of HIV-associated neurocognitive disorders? Journal of the Neurological Sciences. 333: e310. DOI: 10.1016/J.Jns.2013.07.1161  0.522
2012 Robertson K, Liner J, Meeker RB. Antiretroviral neurotoxicity. Journal of Neurovirology. 18: 388-99. PMID 22811264 DOI: 10.1007/s13365-012-0120-3  0.431
2012 Robertson K, Jiang H, Kumwenda J, Supparatpinyo K, Evans S, Campbell TB, Price R, Tripathy S, Kumarasamy N, La Rosa A, Santos B, Silva MT, Montano S, Kanyama C, et al. Improved neuropsychological and neurological functioning across three antiretroviral regimens in diverse resource-limited settings: AIDS Clinical Trials Group study a5199, the International Neurological Study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 55: 868-76. PMID 22661489 DOI: 10.1093/Cid/Cis507  0.452
2012 Elbirt D, Bayon C, Robertson K, Sambatakou H, McNamara P, Kulasegaram R, Schembri G, de Alvaro C, Cabrero E, Guion M, Norton M, Van de Steen O, van Wyk J. Neurocognitive impairment, depression, and anxiety in HIV-1-infected patients across western Europe and Canada: the CRANIum study - ethnicity analysis Journal of the International Aids Society. 15. DOI: 10.7448/Ias.15.6.18276  0.487
2012 Gold J, Peterson J, Lee E, Fuchs D, Price R, Yiannoutsos C, Robertson K, Spudich S. Depression and Mood States and Correlations with Biomarkers of Central Nervous System Disease in Primary-HIV Infection (P01.262) Neurology. 78: P01.262-P01.262. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P01.262  0.478
2012 Okonkwo O, Nakasujja N, Robertson K, Skolasky R, Katabira E, Musisi S, Sacktor N. Longitudinal Cognitive Functioning and Antiretroviral Therapy Use among HIV+ Persons in Uganda (P01.261) Neurology. 78: P01.261-P01.261. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P01.261  0.553
2011 Sacktor N, Miyahara S, Deng L, Evans S, Schifitto G, Cohen BA, Paul R, Robertson K, Jarocki B, Scarsi K, Coombs RW, Zink MC, Nath A, Smith E, Ellis RJ, et al. Minocycline treatment for HIV-associated cognitive impairment: results from a randomized trial. Neurology. 77: 1135-42. PMID 21900636 DOI: 10.1212/Wnl.0B013E31822F0412  0.524
2011 McPhail ME, Robertson KR. Neurocognitive impact of antiretroviral treatment: thinking long-term. Current Hiv/Aids Reports. 8: 249-56. PMID 21837444 DOI: 10.1007/S11904-011-0091-7  0.536
2011 Robertson K, Kumwenda J, Supparatpinyo K, Jiang JH, Evans S, Campbell TB, Price RW, Murphy R, Hall C, Marra CM, Marcus C, Berzins B, Masih R, Santos B, Silva MT, et al. A multinational study of neurological performance in antiretroviral therapy-naïve HIV-1-infected persons in diverse resource-constrained settings. Journal of Neurovirology. 17: 438-47. PMID 21786076 DOI: 10.1007/S13365-011-0044-3  0.598
2011 Meeker RB, Poulton W, Markovic-Plese S, Hall C, Robertson K. Protein changes in CSF of HIV-infected patients: evidence for loss of neuroprotection. Journal of Neurovirology. 17: 258-73. PMID 21556959 DOI: 10.1007/S13365-011-0034-5  0.48
2011 Cohn SE, Jiang H, McCutchan JA, Koletar SL, Murphy RL, Robertson KR, Annabelle AM, Currier JS, Williams PL. Association of ongoing drug and alcohol use with non-adherence to antiretroviral therapy and higher risk of AIDS and death: Results from ACTG 362 Aids Care - Psychological and Socio-Medical Aspects of Aids/Hiv. 23: 775-785. PMID 21293986 DOI: 10.1080/09540121.2010.525617  0.373
2011 Smurzynski M, Wu K, Letendre S, Robertson K, Bosch RJ, Clifford DB, Evans S, Collier AC, Taylor M, Ellis R. Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort. Aids (London, England). 25: 357-65. PMID 21124201 DOI: 10.1097/Qad.0B013E32834171F8  0.483
2010 Wright EJ, Grund B, Robertson K, Brew BJ, Roediger M, Bain MP, Drummond F, Vjecha MJ, Hoy J, Miller C, Penalva De Oliveira AC, Pumpradit W, Shlay JC, El-Sadr W, Price RW. Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons Neurology. 75: 864-873. PMID 20702792 DOI: 10.1212/Wnl.0B013E3181F11Bd8  0.571
2010 Nakasujja N, Skolasky RL, Musisi S, Allebeck P, Robertson K, Ronald A, Katabira E, Clifford DB, Sacktor N. Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda. Bmc Psychiatry. 10: 44. PMID 20537129 DOI: 10.1186/1471-244X-10-44  0.579
2010 Robertson K, Liner J, Hakim J, Sankalé JL, Grant I, Letendre S, Clifford D, Diop AG, Jaye A, Kanmogne G, Njamnshi A, Langford TD, Weyessa TG, Wood C, Banda M, et al. NeuroAIDS in Africa. Journal of Neurovirology. 16: 189-202. PMID 20500018 DOI: 10.3109/13550284.2010.489597  0.582
2010 Liner KJ, Ro MJ, Robertson KR. HIV, antiretroviral therapies, and the brain. Current Hiv/Aids Reports. 7: 85-91. PMID 20425562 DOI: 10.1007/S11904-010-0042-8  0.607
2010 Robertson KR, Su Z, Margolis DM, Krambrink A, Havlir DV, Evans S, Skiest DJ. Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort. Neurology. 74: 1260-6. PMID 20237308 DOI: 10.1212/Wnl.0B013E3181D9Ed09  0.587
2009 Patel K, Ming X, Williams PL, Robertson KR, Oleske JM, Seage GR. Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents. Aids (London, England). 23: 1893-901. PMID 19644348 DOI: 10.1097/Qad.0B013E32832Dc041  0.562
2009 Sacktor N, Nakasujja N, Skolasky RL, Rezapour M, Robertson K, Musisi S, Katabira E, Ronald A, Clifford DB, Laeyendecker O, Quinn TC. HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 49: 780-6. PMID 19622045 DOI: 10.1086/605284  0.616
2009 Robertson K, Liner J, Heaton R. Neuropsychological assessment of HIV-infected populations in international settings. Neuropsychology Review. 19: 232-49. PMID 19455425 DOI: 10.1007/S11065-009-9096-Z  0.605
2009 Marra CM, Zhao Y, Clifford DB, Letendre S, Evans S, Henry K, Ellis RJ, Rodriguez B, Coombs RW, Schifitto G, McArthur JC, Robertson K. Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance. Aids (London, England). 23: 1359-66. PMID 19424052 DOI: 10.1097/Qad.0B013E32832C4152  0.581
2009 Harrington PR, Schnell G, Letendre SL, Ritola K, Robertson K, Hall C, Burch CL, Jabara CB, Moore DT, Ellis RJ, Price RW, Swanstrom R. Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease course. Aids (London, England). 23: 907-15. PMID 19414991 DOI: 10.1097/Qad.0B013E3283299129  0.596
2009 Sacktor N, Nakasujja N, Skolasky RL, Robertson K, Musisi S, Ronald A, Katabira E, Clifford DB. Benefits and risks of stavudine therapy for HIV-associated neurologic complications in Uganda. Neurology. 72: 165-70. PMID 19139369 DOI: 10.1212/01.Wnl.0000339042.96109.86  0.627
2008 Wright EJ, Nunn M, Joseph J, Robertson K, Lal L, Brew BJ. NeuroAIDS in the Asia Pacific Region. Journal of Neurovirology. 14: 465-473. PMID 19031289 DOI: 10.1080/13550280802235932  0.524
2008 Skiest DJ, Krambrink A, Su Z, Robertson KR, Margolis DM. Improved measures of quality of life, lipid profile, and lipoatrophy after treatment interruption in HIV-infected patients with immune preservation: results of ACTG 5170. Journal of Acquired Immune Deficiency Syndromes (1999). 49: 377-83. PMID 18931631 DOI: 10.1097/Qai.0B013E31818Cde21  0.347
2008 Wright E, Brew B, Arayawichanont A, Robertson K, Samintharapanya K, Kongsaengdao S, Lim M, Vonthanak S, Lal L, Sarim C, Huffam S, Li P, Imran D, Lewis J, Lun WH, et al. Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region. Neurology. 71: 50-6. PMID 18591505 DOI: 10.1212/01.Wnl.0000316390.17248.65  0.572
2008 Liner KJ, Hall CD, Robertson KR. Effects of antiretroviral therapy on cognitive impairment. Current Hiv/Aids Reports. 5: 64-71. PMID 18510891 DOI: 10.1007/S11904-008-0011-7  0.5
2008 Robertson K, Kopnisky K, Hakim J, Merry C, Nakasujja N, Hall C, Traore M, Sacktor N, Clifford D, Newton C, Van Rie A, Holding P, Clements J, Zink C, Mielk J, et al. Second assessment of NeuroAIDS in Africa. Journal of Neurovirology. 14: 87-101. PMID 18370346 DOI: 10.1080/13550280701829793  0.439
2007 Robertson KR, Hall CD. Assessment of neuroAIDS in the international setting. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 2: 105-11. PMID 18040833 DOI: 10.1007/S11481-006-9052-0  0.558
2007 Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, ... ... Robertson KR, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 69: 1789-99. PMID 17914061 DOI: 10.1212/01.Wnl.0000287431.88658.8B  0.531
2007 Liner KJ, Hall CD, Robertson KR. Impact of human immunodeficiency virus (HIV) subtypes on HIV-associated neurological disease. Journal of Neurovirology. 13: 291-304. PMID 17849313 DOI: 10.1080/13550280701422383  0.588
2007 Robertson KR, Smurzynski M, Parsons TD, Wu K, Bosch RJ, Wu J, McArthur JC, Collier AC, Evans SR, Ellis RJ. The prevalence and incidence of neurocognitive impairment in the HAART era. Aids (London, England). 21: 1915-21. PMID 17721099 DOI: 10.1097/Qad.0B013E32828E4E27  0.637
2007 Sacktor N, Nakasujja N, Robertson K, Clifford DB. HIV-associated cognitive impairment in sub-Saharan Africa--the potential effect of clade diversity. Nature Clinical Practice. Neurology. 3: 436-43. PMID 17671521 DOI: 10.1038/Ncpneuro0559  0.605
2007 McCutchan JA, Wu JW, Robertson K, Koletar SL, Ellis RJ, Cohn S, Taylor M, Woods S, Heaton R, Currier J, Williams PL. HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients. Aids (London, England). 21: 1109-17. PMID 17502721 DOI: 10.1097/Qad.0B013E3280Ef6Acd  0.547
2007 Marra CM, Maxwell CL, Collier AC, Robertson KR, Imrie A. Interpreting cerebrospinal fluid pleocytosis in HIV in the era of potent antiretroviral therapy. Bmc Infectious Diseases. 7: 37. PMID 17475004 DOI: 10.1186/1471-2334-7-37  0.526
2007 Skiest DJ, Su Z, Havlir DV, Robertson KR, Coombs RW, Cain P, Peterson T, Krambrink A, Jahed N, McMahon D, Margolis DM. Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170. The Journal of Infectious Diseases. 195: 1426-36. PMID 17436222 DOI: 10.1086/512681  0.475
2007 Robertson KR, Nakasujja N, Wong M, Musisi S, Katabira E, Parsons TD, Ronald A, Sacktor N. Pattern of neuropsychological performance among HIV positive patients in Uganda. Bmc Neurology. 7: 8. PMID 17411437 DOI: 10.1186/1471-2377-7-8  0.71
2007 Valcour VG, Sithinamsuwan P, Nidhinandana S, Thitivichianlert S, Ratto-Kim S, Apateerapong W, Shiramizu BT, DeSouza MS, Chitpatima ST, Watt G, Chuenchitra T, Robertson KR, Paul RH, McArthur JC, Kim JH, et al. Neuropsychological abnormalities in patients with dementia in CRF 01_AE HIV-1 infection Neurology. 68: 525-527. PMID 17296919 DOI: 10.1212/01.Wnl.0000253196.78193.C7  0.622
2007 Robertson KR, Parsons TD, Rogers SA, Braaten AJ, Robertson WT, Wilson S, Hall CD. Assessing health-related quality of life in NeuroAIDS: some psychometric properties of the Neurological Quality of Life Questionnaire (NeuroQOL). Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 14: 416-23. PMID 17289392 DOI: 10.1016/J.Jocn.2006.03.004  0.487
2007 Shiramizu B, Ratto-Kim S, Sithinamsuwan P, Nidhinandana S, Thitivichianlert S, Watt G, deSouza M, Chuenchitra T, Sukwit S, Chitpatima S, Robertson K, Paul R, Shikuma C, Valcour V. HIV DNA and dementia in treatment-naïve HIV-1-infected individuals in Bangkok, Thailand. International Journal of Medical Sciences. 4: 13-8. PMID 17211496 DOI: 10.7150/Ijms.4.13  0.577
2007 Parsons TD, Rogers S, Hall C, Robertson K. Motor based assessment of neurocognitive functioning in resource-limited international settings. Journal of Clinical and Experimental Neuropsychology. 29: 59-66. PMID 17162722 DOI: 10.1080/13803390500488538  0.6
2007 Van Rie A, Harrington PR, Dow A, Robertson K. Neurologic and neurodevelopmental manifestations of pediatric HIV/AIDS: a global perspective. European Journal of Paediatric Neurology : Ejpn : Official Journal of the European Paediatric Neurology Society. 11: 1-9. PMID 17137813 DOI: 10.1016/J.Ejpn.2006.10.006  0.592
2007 Parsons TD, Rogers S, Hall C, Robertson K. Erratum: (Journal of Clinical and Experimental Neuropsychology (2007) 29, 1 (59-66)) Journal of Clinical and Experimental Neuropsychology. 29. DOI: 10.1080/13803390601174854  0.476
2006 Parsons TD, Tucker KA, Hall CD, Robertson WT, Eron JJ, Fried MW, Robertson KR. Neurocognitive functioning and HAART in HIV and hepatitis C virus co-infection. Aids (London, England). 20: 1591-5. PMID 16868439 DOI: 10.1097/01.Aids.0000238404.16121.47  0.682
2006 Sacktor N, Nakasujja N, Skolasky R, Robertson K, Wong M, Musisi S, Ronald A, Katabira E. Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa. Neurology. 67: 311-4. PMID 16864825 DOI: 10.1212/01.Wnl.0000225183.74521.72  0.589
2006 Robertson KR, Parsons TD, Sidtis JJ, Hanlon Inman T, Robertson WT, Hall CD, Price RW. Timed Gait test: normative data for the assessment of the AIDS dementia complex. Journal of Clinical and Experimental Neuropsychology. 28: 1053-64. PMID 16840235 DOI: 10.1080/13803390500205684  0.702
2006 Robertson K, Parsons TD, Van Der Horst C, Hall C. Thoughts of death and suicidal ideation in nonpsychiatric human immunodeficiency virus seropositive individuals. Death Studies. 30: 455-69. PMID 16610158 DOI: 10.1080/07481180600614435  0.628
2006 Parsons TD, Braaten AJ, Hall CD, Robertson KR. Better quality of life with neuropsychological improvement on HAART. Health and Quality of Life Outcomes. 4: 11. PMID 16504114 DOI: 10.1186/1477-7525-4-11  0.668
2005 Nakasujja N, Musisi S, Robertson K, Wong M, Sacktor N, Ronald A. Human immunodeficiency virus neurological complications: an overview of the Ugandan experience. Journal of Neurovirology. 11: 26-9. PMID 16540451 DOI: 10.1080/13550280500511782  0.583
2005 Cinque P, Robertson K, Antinori A, Price RW. Neurological complications of HIV infection and AIDS: Current and future perspectives Journal of Neurovirology. 11: 1-5. PMID 16540446 DOI: 10.1080/13550280600558923  0.568
2005 Ellis RJ, Evans SR, Clifford DB, Moo LR, McArthur JC, Collier AC, Benson C, Bosch R, Simpson D, Yiannoutsos CT, Yang Y, Robertson K. Clinical validation of the NeuroScreen. Journal of Neurovirology. 11: 503-11. PMID 16338744 DOI: 10.1080/13550280500384966  0.546
2005 Sacktor NC, Wong M, Nakasujja N, Skolasky RL, Selnes OA, Musisi S, Robertson K, McArthur JC, Ronald A, Katabira E. The International HIV Dementia Scale: a new rapid screening test for HIV dementia. Aids (London, England). 19: 1367-74. PMID 16103767  0.515
2005 Ritola K, Robertson K, Fiscus SA, Hall C, Swanstrom R. Increased human immunodeficiency virus type 1 (HIV-1) env compartmentalization in the presence of HIV-1-associated dementia. Journal of Virology. 79: 10830-4. PMID 16051875 DOI: 10.1128/Jvi.79.16.10830-10834.2005  0.574
2005 Meeker RB, Boles JC, Robertson KR, Hall CD. Cerebrospinal fluid from human immunodeficiency virus--infected individuals facilitates neurotoxicity by suppressing intracellular calcium recovery. Journal of Neurovirology. 11: 144-56. PMID 16036793 DOI: 10.1080/13550280590922757  0.335
2005 Parsons TD, Robertson KR. Editorial comment: treatment of HIV-associated cognitive impairment--beyond HAART. The Aids Reader. 15: 293. PMID 15962452  0.65
2005 Robertson K, Kopnisky K, Mielke J, Appiah K, Hall C, Price R, Kumwenda J, Kanyama C, Amod F, Marra C, Taylor T, Lalloo U, Jelsma J, Holding P, Boivin M, et al. Assessment of neuroAIDS in Africa. Journal of Neurovirology. 11: 7-16. PMID 15960235 DOI: 10.1080/13550280590922711  0.482
2005 Price RW, Robertson K. Editorial comment: Déjà Vu - Neurologic complications of HIV infection in the expanding epidemic Aids Reader. 15: 144. PMID 15786578  0.495
2004 Meeker RB, Boles JC, Bragg DC, Robertson K, Hall C. Development of neuronal sensitivity to toxins in cerebrospinal fluid from HIV-type 1-infected individuals. Aids Research and Human Retroviruses. 20: 1072-86. PMID 15585098 DOI: 10.1089/Aid.2004.20.1072  0.467
2004 Tucker KA, Robertson KR, Lin W, Smith JK, An H, Chen Y, Aylward SR, Hall CD. Neuroimaging in human immunodeficiency virus infection. Journal of Neuroimmunology. 157: 153-62. PMID 15579293 DOI: 10.1016/J.Jneuroim.2004.08.036  0.431
2004 Robertson KR, Kapoor C, Robertson WT, Fiscus S, Ford S, Hall CD. No gender differences in the progression of nervous system disease in HIV infection. Journal of Acquired Immune Deficiency Syndromes (1999). 36: 817-22. PMID 15213565 DOI: 10.1097/00126334-200407010-00008  0.598
2004 Robertson KR, Robertson WT, Ford S, Watson D, Fiscus S, Harp AG, Hall CD. Highly active antiretroviral therapy improves neurocognitive functioning. Journal of Acquired Immune Deficiency Syndromes (1999). 36: 562-6. PMID 15097298 DOI: 10.1097/00126334-200405010-00003  0.475
2002 Inman TH, Esther JK, Robertson WT, Hall CD, Robertson KR. The Minnesota Multiphasic Personality Inventory-2 across the human immunodeficiency virus spectrum. Assessment. 9: 24-30. PMID 11911231 DOI: 10.1177/1073191102009001004  0.561
2001 Pilcher CD, Shugars DC, Fiscus SA, Miller WC, Menezes P, Giner J, Dean B, Robertson K, Hart CE, Lennox JL, Eron JJ, Hicks CB. HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public health. Aids (London, England). 15: 837-45. PMID 11399956 DOI: 10.1097/00002030-200105040-00004  0.566
2000 Shepard RN, Schock J, Robertson K, Shugars DC, Dyer J, Vernazza P, Hall C, Cohen MS, Fiscus SA. Quantitation of human immunodeficiency virus type 1 RNA in different biological compartments. Journal of Clinical Microbiology. 38: 1414-8. PMID 10747117 DOI: 10.1128/Jcm.38.4.1414-1418.2000  0.381
1999 Meeker RB, Robertson K, Barry T, Hall C. Neurotoxicity of CSF from HIV-infected humans. Journal of Neurovirology. 5: 507-18. PMID 10568888 DOI: 10.3109/13550289909045380  0.506
1999 Vaughn BV, Robertson K, Kapoor C, Kalkowski J, Hall C. THE EFFECT OF GENDER ON EVOKED POTENTIAL MEASURES IN HIV Journal of Clinical Neurophysiology. 16: 180. DOI: 10.1097/00004691-199903000-00047  0.547
1998 Corder EH, Robertson K, Lannfelt L, Bogdanovic N, Eggertsen G, Wilkins J, Hall C. HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy. Nature Medicine. 4: 1182-4. PMID 9771753 DOI: 10.1038/2677  0.463
1998 Robertson K, Fiscus S, Kapoor C, Robertson W, Schneider G, Shepard R, Howe L, Silva S, Hall C. CSF, plasma viral load and HIV associated dementia. Journal of Neurovirology. 4: 90-4. PMID 9531015 DOI: 10.3109/13550289809113485  0.52
1997 Mesenheimer J, Lyles R, Seiller-Moiseiwistch F, Wilkins J, Robertson K, Kalkowski J, Hall C. Relationship between P3 event related potentials and neuropsychological variables over time in HIV+ patients Electroencephalography and Clinical Neurophysiology. 102: P21. DOI: 10.1016/S0013-4694(97)86308-0  0.497
1996 Hall M, Whaley R, Robertson K, Hamby S, Wilkins J, Hall C. The correlation between neuropsychological and neuroanatomic changes over time in asymptomatic and symptomatic HIV-1-infected individuals. Neurology. 46: 1697-1702. PMID 8649573 DOI: 10.1212/Wnl.46.6.1697  0.543
1995 Wilkins JW, Hamby SL, Robertson KR, Knorr KL, Barry NS, Hall CD. The Profile of Mood States as a Screening Test for Major Depression in HIV+ Patients Assessment. 2: 181-188. DOI: 10.1177/107319119500200208  0.416
1993 Robertson KR, Stern RA, Hall CD, Perkins DO, Wilkins JW, Gortner DT, Donovan MK, Messenheimer JA, Whaley R, Evans DL. Vitamin B12 deficiency and nervous system disease in HIV infection. Archives of Neurology. 50: 807-11. PMID 8352665 DOI: 10.1001/archneur.1993.00540080018007  0.385
1993 Robertson KR, Wilkins JW, Handy J, van der Horst C, Robertson WT, Fryer JG, Evans D, Hall CD. Psychoimmunology and aids: Psychological distress and herpes simplex virus in human immunodeficiency virus infected individuals Psychology & Health. 8: 317-327. DOI: 10.1080/08870449308401925  0.516
1992 Robertson KR, Hall CD. Human immunodeficiency virus-related cognitive impairment and the acquired immunodeficiency syndrome dementia complex. Seminars in Neurology. 12: 18-27. PMID 1615236 DOI: 10.1055/S-2008-1041153  0.324
1992 Messenheimer JA, Robertson KR, Wilkins JW, Kalkowski JC, Hall CD. Event-related potentials in human immunodeficiency virus infection. A prospective study. Archives of Neurology. 49: 396-400. PMID 1558522 DOI: 10.1001/Archneur.1992.00530280086027  0.541
1992 Messenheimer JA, Robertson KR, Kalkowski JC, Hall CD. Event Related Potentials (P3) in AIDS American Journal of Eeg Technology. 32: 147-160. DOI: 10.1080/00029238.1992.11080402  0.473
1991 Wilkins JW, Robertson KR, Snyder CR, Robertson WK, van der Horst C, Hall CD. Implications of self-reported cognitive and motor dysfunction in HIV-positive patients. The American Journal of Psychiatry. 148: 641-3. PMID 2018167 DOI: 10.1176/Ajp.148.5.641  0.467
1991 Hall CD, Snyder CR, Messenheimer JA, Wilkins JW, Robertson WT, Whaley RA, Robertson KR. Peripheral neuropathy in a cohort of human immunodeficiency virus-infected patients. Incidence and relationship to other nervous system dysfunction. Archives of Neurology. 48: 1273-4. PMID 1668978 DOI: 10.1001/Archneur.1991.00530240077026  0.371
Show low-probability matches.